Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Other Non-Current Liabilities: 2019-2024

Historic Other Non-Current Liabilities for Fulcrum Therapeutics (FULC) over the last 4 years, with Dec 2024 value amounting to $197,000.

  • Fulcrum Therapeutics' Other Non-Current Liabilities changed negligibly% to $197,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $197,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $197,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Other Non-Current Liabilities of $197,000 as of FY2024, which was down 0.00% from $197,000 recorded in FY2023.
  • Fulcrum Therapeutics' 5-year Other Non-Current Liabilities high stood at $197,000 for FY2022, and its period low was $197,000 during FY2022.
  • Over the past 3 years, Fulcrum Therapeutics' median Other Non-Current Liabilities value was $197,000 (recorded in 2024), while the average stood at $197,000.